Background/Aim: Because cholecystokinin and peptide YY are gut hormones with potent effects on gastrointestinal motility, we determined whether abnormalities of cholecystokinin and peptide YY exist in slow transit constipation. Methods: Plasma concentrations of these hormones before, during and after intraduodenal infusion of a liquid meal in 21 patients with slow transit constipation were compared with the results in 8 healthy controls. Results: Fasting levels of plasma cholecystokinin (3.1 ± 0.2 vs. 2.4 ± 0.2 pM; p = 0.02) were higher in patients. Basal plasma peptide YY (11.4 ± 1.4 vs. 8.9 ± 0.7 pM; p = 0.1) tended to be higher in patients. After the meal (60–90 min), incremental cholecystokinin (p < 0.05), but not peptide YY, was significantly higher in patients. During intraduodenal infusion of the meal (0–60 min), incremental plasma cholecystokinin (251 ± 20 pM·min) and peptide YY (1,146 ± 186 pM·min) in patients were almost similar to control values (262 ± 22 and 901 ± 166 pM·min). Gallbladder volumes before, during and after the meal were not different between the 2 groups. Gastric emptying of a solid meal was delayed in the majority of patients (12 of 18). Abnormalities of plasma cholecystokinin were observed only in patients with delayed gastric emptying. Conclusion: Plasma levels of cholecystokinin are elevated in the fasting state and decrease more slowly after stimulation, but maximum release in response to intestinal nutrients is not altered in patients with slow transit constipation. The abnormality seems to be confined to a subgroup of patients with delayed gastric emptying.

1.
Bassotti G, Stanghellini V, Chiarioni G, Germani U, De Giorgio R, Vantini R, Morelli A, Cornaldesi R: Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci 1996;41:1999&ndash;2005.
[PubMed]
2.
Glia A, Lindberg G: Antroduodenal manometry findings in patients with slow-transit constipation. Scand J Gastroenterol 1998;33:55&ndash;62.
[PubMed]
3.
Mollen RMGH, Hopman WPM, Kuijpers HHC, Jansen JBMJ: Abnormalities of upper gut motility in patients with slow transit constipation. Eur J Gastroenterol Hepatol 1999;11:701&ndash;708.
[PubMed]
4.
Van der Sijp JRM, Kamm MA, Nightingale JMD, Britton KE, Granowska M, Mather SJ, Akkermans LMA, Lennard-Jones JE: Disturbed gastric and small bowel transit in severe idiopathic constipation. Dig Dis Sci 1993;38:837&ndash;844.
[PubMed]
5.
MacDonald A, Baxter JN, Bessent RG, Gray HW, Finlay IG: Gastric emptying in patients with slow transit constipation following childbirth and due to idiopathic slow transit. Br J Surg 1997;84:1141&ndash;1143.
[PubMed]
6.
Penning C, Gielkens HAJ, Delemarre JBVM, Lamers CBHW, Masclee AAM: Gall bladder emptying in severe idiopathic constipation. Gut 1999;45:264&ndash;268.
[PubMed]
7.
Walsh JH: Gastrointestinal hormones; in Johnson LR (ed): Physiology of the Gastrointestinal Tract, ed 3. New York, Raven Press, 1994, vol 1, pp 1&ndash;128.
8.
Adrian TE, Ferri G-L, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR: Human distribution and release of a putative new gut hormone, peptide YY (PYY). Gastroenterology 1985;89:1070&ndash;1077.
[PubMed]
9.
Hopman WPM, Kerstens PJSM, Jansen JBMJ, Rosenbusch G, Lamers CBHW: Effect of graded physiologic doses of cholecystokinin on gallbladder contraction measured by ultrasonography. Determination of threshold, dose-response relationships and comparison with intraduodenal bilirubin output. Gastroenterology 1985;89:1242&ndash;1247.
[PubMed]
10.
Liddle RA, Gertz BJ, Kanayama S, Beccaria L, Coker LD, Turnbull TA, Morita ET: Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. J Clin Invest 1989;84:1220&ndash;1225.
[PubMed]
11.
Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JBMJ, Zach D, Rovati LC, Stalder GA: Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989;ii:12&ndash;15.
12.
Hildebrand P, Beglinger C, Gyr K, Jansen JBMJ, Rovati LC, Zuercher M, lamers CBHW, Setnikar I, Stalder GA: Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J Clin Invest 1990;85:640&ndash;646.
[PubMed]
13.
Liddle RA, Morita ET, Conrad CK, Williams JA: Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 1985;77:992&ndash;996.
14.
Fried M, Erlacher U, Schwizer W, L&ouml;chner C, Koerfer J, Beglinger C, Jansen JB, Lamers CB, Harder F, Bischof-Delaloye A, Stalder GA, Rovati L: Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991;101:503&ndash;511.
[PubMed]
15.
Snape WJ, Matarazzo SA, Cohen S: Effect of eating and gastrointestinal hormones on human colonic myoelectrical and motor activity. Gastroenterology 1978;75:373&ndash;378.
[PubMed]
16.
Renny A, Snape WJ, Sun EA, London R, Cohen S: Role of cholecystokinin in the gastrocolonic response to a fat meal. Gastroenterology 1983;85:17&ndash;21.
[PubMed]
17.
Mangel AW, Brazer SR, Smith JW, Fitz JG, Taylor IL: Inhibition of colonic motility by cholecystokinin. Ann Med 1992;24:341&ndash;342.
[PubMed]
18.
O&rsquo;Brien MD, Camilleri M, Thomforde GM, Wiste JA, Hanson RB, Zinsmeister AR: Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit. Dig Dis Sci 1997;42:26&ndash;33.
[PubMed]
19.
Pappas TN, Debas HT, Chang AM, Taylor IL: Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs. Gastroenterology 1986;91:1386&ndash;1389.
[PubMed]
20.
Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR: Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 1987;28:166&ndash;170.
[PubMed]
21.
Van der Sijp JRM, Kamm MA, Nightingale JMD, Akkermans LMA, Ghatei MA, Bloom SR, Jansen JBMJ, Lennard-Jones JE: Circulating gastrointestinal hormone abnormalities in patients with severe idiopathic constipation. Am J Gastroenterol 1998;93:1351&ndash;1356.
[PubMed]
22.
Penning C, Delemarre JBVM, Biemond I, Lamers CBHW, Masclee AAM: Proximal and distal gut hormone secretion in slow transit constipation. Eur J Gastroenterol Hepatol 1999;11:A19.
23.
Thompson WG, Creed F, Drossmann DA, Heaton KW, Mazacca G: Functional bowel disorders and chronic functional abdominal pain. Gastroenterol Int 1992;5:75&ndash;91.
24.
Devroede G: Constipation; in Sleisinger M, Fordtran J (eds): Gastrointestinal Disease: Pathophysiology, Diagnosis, Treatment. Philadelphia, Saunders, 1988, pp 331&ndash;368.
25.
Devroede G: Use of radio-opaque markers technique to measure colorectal transit time; in Schuster MS (ed): Atlas of Gastrointestinal Motility. Baltimore, Williams and Wilkins, 1993, pp 57&ndash;75.
26.
Arhan P, Devroede G, Jehannin B, Lanza M, Faverdin C, Dornic C, Persoz B, Tetreault L, Perey B, Pellerin D: Segmental colonic transit time. Dis Colon Rectum 1981;24:625&ndash;629.
[PubMed]
27.
Kuijpers JHC: Transit time measurement; in Buchman P, Bruhlman W (eds): Investigations of Anorectal Function Disorders. Berlin, Springer, 1993, pp 115&ndash;118.
28.
Bond JH, Levitt MD: Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med 1975;85:546&ndash;555.
[PubMed]
29.
Salemans JMJI, Nagengast FM, Tangerman A, van Schaik A, Hopman WPM, de Haan AFJ, Jansen JBMJ: Effect of ageing on postprandial conjugated and unconjugated serum bile acid levels in healthy subjects. Eur J Clin Invest 1993;23:192&ndash;198.
[PubMed]
30.
Smout AJM, Akkermans LMA, Roelofs JMM, Pasma FG, Oei HY, Wittebol P: Gastric emptying and postprandial symptoms after Billroth II resection. Surgery 1987;101:27&ndash;34.
[PubMed]
31.
Hopman WPM, Brouwer WFM, Rosenbusch G, Jansen JBMJ, Lamers CBHW: A computerized method for rapid quantification of gallbladder volume from real-time sonograms. Radiology 1985;154:236&ndash;237.
[PubMed]
32.
Jansen JBMJ, Lamers CBHW: Radioimmunoassay of cholecystokinin: Production and evaluation of antibodies. J Clin Chem Clin Biochem 1983;21:387&ndash;394.
[PubMed]
33.
Jansen JBMJ, Lamers CBHW: Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta 1983;131:305&ndash;316.
[PubMed]
34.
Jansen JBMJ, Lamers CBHW: Molecular forms of cholecystokinin in plasma from normal and gastrectomized human subjects following a fat meal. Peptides 1987;8:801&ndash;805.
[PubMed]
35.
Maas MIM, Hopman WPM, Katan MB, Jansen JBMJ: Release of peptide YY and inhibition of gastric acid secretion by long-chain and medium-chain triglycerides but not by sucrose polyester in men. Eur J Clin Invest 1998;28:123&ndash;130.
[PubMed]
36.
Van Battum PLH, Hopman WPM, Salemans JMJI, Kuijpers JHC, Nagengast FM, Jansen JBMJ: Impaired release of peptide YY in patients with proctocolectomy and ileal pouch-anal anastomosis. Scand J Gastroenterol 1999;34:404&ndash;408.
[PubMed]
37.
Edelbroek M, Horowitz M, Maddox A, Bellen J: Gastric emptying and intragastric distribution of oil in the presence of a liquid or a solid meal. J Nucl Med 1992;33:1283&ndash;1290.
[PubMed]
38.
Fried M, Erlacher U, Schwizer W, L&ouml;chner C, Koerfer J, Beglinger C, Jansen JB, Lamers CB, Harder F, Bischof-Delaloye A, Stalder GA, Rovati L: Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Gastroenterology 1991;101:503&ndash;511.
[PubMed]
39.
Caride VJ, Prokop EK, Troncale FJ, Buddoura W, Winchenbach K, McCallum RW: Scintigraphic determination of small intestinal transit time: Comparison with the breath hydrogen technique. Gastroenterology 1984;86:714&ndash;720.
[PubMed]
40.
Hirakawa M, Lida M, Kohrogi N, Fujishima M: Hydrogen breath test assessment of orocecal transit time: Comparison with barium meal study. Am J Gastroenterol 1988;83:1361&ndash;1363.
[PubMed]
41.
Jorge JMN, Wexner SD, Ehrenpreis ED: The lactulose hydrogen breath test as a measure of orocaecal transit time. Eur J Surg 1994;160:409&ndash;416.
[PubMed]
42.
Marzio L, Del Bianco R, Delle Donne M, Pieramico O, Cuccurullo F: Mouth-to-cecum transit time in patients affected by chronic constipation: Effect of glucomannan. Am J Gastroenterol 1989;84:888&ndash;891.
[PubMed]
43.
Altomare DF, Portincasa P, Rinaldi M, Di Ciaula A, Martinelli E, Amoruso A, Palasciano G, Memeo V: Slow transit constipation: Solitary symptom of a systemic gastrointestinal disease. Dis Colon Rectum 1999;42:231&ndash;240.
[PubMed]
44.
Niederau C, Faber S, Karaus M: Cholecystokinin&rsquo;s role in regulation of colonic motility in health and in irritable bowel syndrome. Gastroenterology 1992;102:1889&ndash;1898.
[PubMed]
45.
Kellow JE, Miller LJ, Phillips SF, Haddad AC, Zinsmeister AR, Charboneau JW: Sensitivities of human jejunum, ileum, proximal colon and gallbladder to cholecystokinin octapeptide. Am J Physiol 1987;252:G345&ndash;G356.
[PubMed]
46.
Neri M, Schiavone C, Grossi E, Laterza F, Cuccurullo F: Gallbladder motility in slow-transit constipation: Evidence toward a generalized motility disorder. Gastroenterology 1994;104:A558.
You do not currently have access to this content.